Leukemia can spread to the central nervous system (CNS) and gonads, which are shielded from chemotherapy. Treatment strategies for leukemia aim to eradicate disease while minimizing long-term damage.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Leukemia, primarily a bone marrow disease, can infiltrate sanctuary sites like the gonads and central nervous system (CNS).
These sites are partially shielded from systemic chemotherapy, allowing leukemic cells to persist undetected.
Ovarian leukemia is rare, while testicular leukemia is relatively uncommon, and CNS leukemia requires specific management strategies.
Purpose:
To review the challenges and strategies for managing leukemia in sanctuary sites, particularly the CNS and gonads.
To discuss the rationale for and against prophylactic measures in gonadal leukemia.
To outline treatment approaches for CNS leukemia, emphasizing efficacy and minimizing neurotoxicity.
Summary:
Leukemic cells can persist in gonads and CNS, necessitating tailored treatment strategies.
Prophylactic radiotherapy and biopsies are generally not recommended for ovarian or testicular leukemia due to rarity.
For testicular leukemia, bilateral biopsies, significant irradiation, and reinduction therapy are advised.
CNS leukemia prophylaxis and treatment aim for complete eradication while minimizing long-term neurological damage.
Treatment decisions for CNS leukemia, including the use of irradiation and Ommayadrains, should be individualized based on leukemia type (e.g., ALL, T-cell leukemia) and risk stratification.
Impact:
Informed clinical decision-making for leukemia management in sanctuary sites.
Optimization of treatment protocols to improve outcomes and reduce long-term side effects.
Enhanced understanding of leukemia's behavior in specific anatomical locations, guiding future research and therapeutic development.